ELV - Company ID 0001156039
Elevance Health, Inc. trades as ELV and has a market capitalization of $91.29 B, making it the #177 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $199.13B, up 12.5% from the prior year and net income of $5.66B. This page tracks Elevance Health, Inc. through 1,000 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years Elevance Health, Inc.'s revenue grew from $84.86B to $199.13B, a compound annual growth rate of 9.9%. Net profit margin compressed from 2.9% to 2.8% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| Insider sale notice | 144 | 2026-05-19 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
Elevance Health supports health at every life stage, offering health plans and clinical, behavioral, pharmacy, and complex-care solutions that promote whole health.
The largest companies sharing Elevance Health, Inc.'s SEC industry classification (hospital & medical service plans).
Elevance Health, Inc. (ELV) has a market capitalization of $91.29 B as of 2026-07-09, ranking #177 among US-listed companies.
Elevance Health, Inc. reported revenue of $199.13B for fiscal year 2025, an increase of 12.5% year over year.
Yes. Elevance Health, Inc. reported net income of $5.66B in its latest fiscal year.